Back
Evolus 10K Form
Sell
29
EOLS
Evolus
Last Price:
13.51
Seasonality Move:
65.98%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive EOLS News And Ratings
See the #1 stock for the next 7 days that we like better than EOLS
EOLS Financial Statistics
Sales & Book Value
| Annual Sales: | $202.09M |
|---|---|
| Cash Flow: | $-7.13M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $0.09 |
| Price / Book: | 145.24 |
Profitability
| EPS (TTM): | -0.90000 |
|---|---|
| Net Income (TTM): | $-55.46M |
| Gross Margin: | $140.53M |
| Return on Equity: | -7724.23% |
| Return on Assets: | -26.5% |
Evolus Earnings Forecast
Key Evolus Financial Ratios
- The Gross Profit Margin over the past 6 years for EOLS is 69.54%.
- The Selling, General & Administrative Expenses for EOLS have been equal to 81.62% of Gross Profit Margin.
- The Research & Development expenses have been 7.63% of Revenue.
- The Interest Expense is -22.42% of Operating Income.
- The Net Earning history of EOLS is -30.52% of Total Revenues.
- Per Share Earnings over the last 9 years have been positive in 4 years.
Evolus Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Pharmaceuticals |
| Sector: | Health Care |
| Current Symbol: | EOLS |
| CUSIP: | 30052C |
| Website: | evolus.com |
Debt
| Debt-to-Equity Ratio: | 20.58 |
|---|---|
| Current Ratio: | 2.47 |
| Quick Ratio: | 2.13 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 214.44 |